Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05835921 · ClinicalTrials.gov registry record · NA

Enhancing Prospective Thinking in Early Recovery

A NA study of Substance Use Disorders and Stimulant Use, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
88
Enrollment target
1
Study location

NCT05835921 is a NA study of Substance Use Disorders and Stimulant Use that is actively recruiting participants, run by Indiana University. The registered enrollment target is 88 participants, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05835921, a NA study of Substance Use Disorders and Stimulant Use, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
88 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing stimulant use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering stimulant use disorder (StUD) persons. The main question\[s\] this trial aims to answer are: * Will the Virtual Reality (VR) intervention decrease the number of stimulant use days? * Will the VR intervention produce longer abstinence periods during follow-up visits? * Will the VR intervention increase stimulant drug abstinence rates? * Will the VR intervention increase future self-identification? * Will the VR intervention increase self-reported future time perspective? * Will the VR intervention increase preference for delayed rewards in a laboratory delay discounting task on the study day? * Will the VR intervention produce gains in the behavioral effects of future self-identification, future time perspective, and delayed rewards at the 30-day and 6-month follow-ups? Researchers will compare the experimental and control groups to see if there are differences in the results for the questions outlined above.

Interventions

  • DEVICE Virtual Reality

Study Locations (1)

Indiana

  • Indiana University School of Medicine - Goodman Hall - Indianapolis

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2023-03-28
Est. Completion 2026-05-01
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT05835921

The ClinicalTrials.gov registry entry for NCT05835921 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (82% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality is the first listed.

NCT05835921 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT05835921 about?

NCT05835921 is a clinical study titled "Enhancing Prospective Thinking in Early Recovery". The goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing stimulant use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering stimulant use disorder ...

What is the current status of trial NCT05835921?

This trial is currently recruiting. It is a NA study. The enrollment target is 88 participants. The study started on 2023-03-28. Estimated completion is 2026-05-01.

What conditions does trial NCT05835921 study?

This clinical trial studies the following conditions: Substance Use Disorders, Stimulant Use.

What interventions are being tested in trial NCT05835921?

The interventions under investigation include: Virtual Reality (DEVICE).

Who is sponsoring clinical trial NCT05835921?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05835921 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.